Avid Bioservices Inc (CDMO)

[sunstar]

Genentech completed and published a (Peregrine Anti-PS) imaging study. What other activities are in the works?

http://www.nucmedbio.com/article/S0969-8051(12)00230-2/abstract

“The results demonstrate the ability of 89Zr-PGN635 to image drug-induced apoptosis in animal models and corroborate our hypothesis that radiolabeled antibodies binding to intracellular targets transiently exposed on the cell surface during apoptosis can be employed for detection of tumor response to therapy.”

“We would like to thank Philip Thorpe and Nicholas van Bruggen for helpful discussions, Peregrine Pharmaceuticals, Inc. for providing PGN635...”

“The chimeric PS-targeting monoclonal antibody bavituximab is currently in Phase 2 clinical trials for treatment of various malignancies in combination with chemotherapy.”

PPHM VOLUME: Take a look at a PPHM monthly chart. A year ago volume really started to pick up. Over the last six months it established another quantum ramp up. As 2012 wraps, PPHM volume is just ready to go over 80 million shares for the month of December.

Volume precedes...

Best of New Years to all.

IMO

sunstar